Insider Actions for Turning Point Therapeutics Inc.
– Purchase
– Sale
1
– Number of Transactions
Date
Name
Transaction
Value
| 05/31/2022 |
Steve M Sabus SVP & Chief Commercial Officer |
36,667 | Award at $0 per share. | 0 |
| 04/11/2022 |
Brian Sun SVP & General Counsel |
45,000 | Award at $0 per share. | 0 |
| 02/09/2022 |
Athena M. Countouriotis President & CEO; Director |
62,400 | Award at $0 per share. | 0 |
| 02/09/2022 |
Mohammad Hirmand EVP & Chief Medical Officer |
15,000 | Award at $0 per share. | 0 |
| 02/09/2022 |
Mohammad Hirmand EVP & Chief Medical Officer |
18,983 | Award at $0 per share. | 0 |
| 02/09/2022 |
Andrew Partridge EVP & Chief Commercial Officer |
16,283 | Award at $0 per share. | 0 |
| 02/09/2022 |
Paolo Tombesi EVP & Chief Financial Officer |
16,283 | Award at $0 per share. | 0 |
| 02/09/2022 |
Annette C. North EVP & General Counsel |
16,283 | Award at $0 per share. | 0 |
| 02/09/2022 |
Siegfried Reich EVP & Chief Scientific Officer |
13,567 | Award at $0 per share. | 0 |
| 02/09/2022 |
Athena M. Countouriotis President & CEO; Director |
2,971 | Disposition at $36.3 per share. | 107,847 |
| 02/09/2022 |
Mohammad Hirmand EVP & Chief Medical Officer |
669 | Disposition at $36.3 per share. | 24,284 |
| 02/09/2022 |
Andrew Partridge EVP & Chief Commercial Officer |
221 | Disposition at $36.3 per share. | 8,022 |
| 02/09/2022 |
Annette C. North EVP & General Counsel |
669 | Disposition at $36.3 per share. | 24,284 |
| 02/09/2022 |
Siegfried Reich EVP & Chief Scientific Officer |
397 | Disposition at $36.3 per share. | 14,411 |
| 08/30/2021 |
Annette C. North EVP & General Counsel |
10,000 | Disposition at $80 per share. | 800,000 |
| 08/30/2021 |
Annette C. North EVP & General Counsel |
10,000 | Derivative/Non-derivative trans. at $17 per share. | 170,000 |
| 07/26/2021 |
Paolo Tombesi EVP & Chief Financial Officer |
13,600 | Award at $0 per share. | 0 |
| 07/14/2021 |
Andrew Partridge EVP & Chief Commercial Officer |
1,869 | Disposition at $74.9 per share. | 139,988 |
| 06/21/2021 |
Mark J. Alles Director |
2,000 | Acquisition at $81.34 per share. | 162,680 |
| 06/15/2021 |
Annette C. North EVP & General Counsel |
6,634 | Disposition at $77.82 per share. | 516,257 |
| 06/15/2021 |
Annette C. North EVP & General Counsel |
2,700 | Disposition at $77.37 per share. | 208,899 |
| 06/15/2021 |
Annette C. North EVP & General Counsel |
5,666 | Disposition at $75.94 per share. | 430,276 |
| 06/15/2021 |
Annette C. North EVP & General Counsel |
15,000 | Derivative/Non-derivative trans. at $17 per share. | 255,000 |
| 05/06/2021 |
Annette C. North EVP & General Counsel |
5,882 | Derivative/Non-derivative trans. at $17 per share. | 99,994 |
| 03/23/2021 |
Brian L. Baker SVP of Finance and Admin. |
100 | Disposition at $104.17 per share. | 10,417 |
| 03/23/2021 |
Brian L. Baker SVP of Finance and Admin. |
3,890 | Disposition at $102.84 per share. | 400,047 |
| 03/23/2021 |
Brian L. Baker SVP of Finance and Admin. |
8,061 | Disposition at $102.23 per share. | 824,076 |
| 03/23/2021 |
Brian L. Baker SVP of Finance and Admin. |
5,010 | Disposition at $100.98 per share. | 505,909 |
| 03/23/2021 |
Brian L. Baker SVP of Finance and Admin. |
1,996 | Disposition at $100.07 per share. | 199,739 |
| 03/23/2021 |
Brian L. Baker SVP of Finance and Admin. |
4,459 | Disposition at $98.76 per share. | 440,370 |
| 03/23/2021 |
Brian L. Baker SVP of Finance and Admin. |
4,919 | Disposition at $97.89 per share. | 481,520 |
| 03/23/2021 |
Brian L. Baker SVP of Finance and Admin. |
10,688 | Derivative/Non-derivative trans. at $7.43 per share. | 79,411 |
| 03/23/2021 |
Brian L. Baker SVP of Finance and Admin. |
4,545 | Derivative/Non-derivative trans. at $5.12 per share. | 23,270 |
| 03/23/2021 |
Brian L. Baker SVP of Finance and Admin. |
1,298 | Derivative/Non-derivative trans. at $3.2 per share. | 4,153 |
| 03/23/2021 |
Brian L. Baker SVP of Finance and Admin. |
11,904 | Derivative/Non-derivative trans. at $2.19 per share. | 26,069 |
